Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Seattle Genetics Regains Rights To Antibody From Genentech

Oct. 9, 2002

Seattle Genetics Regains Rights To Antibody From Genentech

Oct. 9, 2002

Targeted Genetics Reports Early Positive CF Gene Therapy Data

Oct. 7, 2002

Targeted Genetics Reports Early Positive CF Gene Therapy Data

Oct. 7, 2002

Cephalon Buys Back Actiq From Elan For $50M In Cash

Oct. 4, 2002

Cephalon Buys Back Actiq From Elan For $50M In Cash

Oct. 4, 2002

Elan's Abelcet, Sales Force Go To Enzon For $370M

Oct. 3, 2002

Enzon Inc. signed an agreement with troubled Irish pharmaceutical company Elan Corp. plc to buy the North American and Japanese rights to Abelcet, Elan's drug for severe fungal infections, for $370 million in cash. (BioWorld Today)

Elan's Abelcet, Sales Force Go To Enzon For $370M

Oct. 3, 2002

Enzon Inc. signed an agreement with troubled Irish pharmaceutical company Elan Corp. plc to buy the North American and Japanese rights to Abelcet, Elan's drug for severe fungal infections, for $370 million in cash. (BioWorld Today)

Genelabs Synthesizes Family Of DNA-Binding Fungicidal Molecules

Oct. 1, 2002

Genelabs Synthesizes Family Of DNA-Binding Fungicidal Molecules

Oct. 1, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...